Inhibikase Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $24.9M
Liabilities Breakdown FY2022
Total Liabilities: $3.9M
Asset Breakdown
Total Assets: $24.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.2M | 28.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $236.5K | 0.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $17.5M | 70.2% |
Liabilities Breakdown
Total Liabilities: $3.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 29.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.7M | 70.5% |